CME PE Ratio & Valuation, Is CME Overvalued

Historical Valuation

CME Group Inc (CME) is now in the Fair zone, suggesting that its current forward PE ratio of 23.59 is considered Fairly compared with the five-year average of 24.27. The fair price of CME Group Inc (CME) is between 278.67 to 355.61 according to relative valuation method.

Relative Value

Fair Zone

278.67-355.61

Current Price：303.75

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is CME Group Inc (CME) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

CME Group Inc (CME) has a current Price-to-Book (P/B) ratio of 3.44. Compared to its 3-year average P/B ratio of 2.97, the current P/B ratio is approximately 16.02% higher. Relative to its 5-year average P/B ratio of 2.85, the current P/B ratio is about 20.79% higher. CME Group Inc (CME) has a Forward Free Cash Flow (FCF) yield of approximately 4.20%. Compared to its 3-year average FCF yield of 4.16%, the current FCF yield is approximately 1.06% lower. Relative to its 5-year average FCF yield of 3.82%, the current FCF yield is about 10.06% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for CME competitors is 9.28, providing a benchmark for relative valuation. CME Group Inc Corp (CME.O) exhibits a P/S ratio of 14.62, which is 57.55% above the industry average. Given its robust revenue growth of 26.71%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of CME increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of CME in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is CME currently overvalued or undervalued?

What is CME Group Inc (CME) fair value?

CME's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of CME Group Inc (CME) is between 278.67 to 355.61 according to relative valuation method.

How does CME's valuation metrics compare to the industry average?

The average P/S ratio for CME's competitors is 9.28, providing a benchmark for relative valuation. CME Group Inc Corp (CME) exhibits a P/S ratio of 14.62, which is 57.55% above the industry average. Given its robust revenue growth of 26.71%, this premium appears sustainable.

What is the current P/B ratio for CME Group Inc (CME) as of Mar 11 2026?

As of Mar 11 2026, CME Group Inc (CME) has a P/B ratio of 3.44. This indicates that the market values CME at 3.44 times its book value.

What is the current FCF Yield for CME Group Inc (CME) as of Mar 11 2026?

As of Mar 11 2026, CME Group Inc (CME) has a FCF Yield of 4.20%. This means that for every dollar of CME Group Inc's market capitalization, the company generates 4.20 cents in free cash flow.

What is the current Forward P/E ratio for CME Group Inc (CME) as of Mar 11 2026?

As of Mar 11 2026, CME Group Inc (CME) has a Forward P/E ratio of 23.59. This means the market is willing to pay $23.59 for every dollar of CME Group Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for CME Group Inc (CME) as of Mar 11 2026?

As of Mar 11 2026, CME Group Inc (CME) has a Forward P/S ratio of 14.62. This means the market is valuing CME at $14.62 for every dollar of expected revenue over the next 12 months.

CME Valuation